Paravellum agreed to provide data infrastructure technology for the ConvergePartners Synapse dental AI series. The agreement structures clinical records for cross-product information linkage, according to the Paravellum launch announcement. Currently, over 500 clinics use the platform.
Partnership Roles in Development
Paravellum designs and develops software using AI and cloud technology for the Synapse series. The company also implements the underlying technical architecture. ConvergePartners defines product requirements based on clinical knowledge.
Synapse Dental AI Data Infrastructure Capabilities
Ontology and Data Types
The technology structures clinical data on a per-patient basis. The platform organizes information relationships using dental clinical ontology. These medical records track patient status, test results, specific tooth surface parts, medical actions, materials, measuring methods, interventions, and chronological follow-ups.
Standardization and Security Architecture
Paravellum provides a data integration infrastructure designed for interoperability. The system uses Japanese medical information standard codes. The technical architecture considers patient information protection, data usage rights, and access control. The Synapse platform features SOC2 compliance and regular security audits, according to the Synapse product page.
Synapse Modules and Insurance Tools
Synapse modules include Synapse Myo, which supports oral myofunctional therapy. The Synapse Sprout module supports pediatric oral function development deficiency inspection. The platform includes a dental insurance point navigation system.
How Medical Workers and Patients Use Synapse
Medical Workers
Medical workers use the new infrastructure to directly associate clinical test results, historical treatment records, and overall patient status across different visits. Dental professionals manage recording, explanation, and continuous management tasks.
Patients and Guardians
Patients use the platform to understand oral function status. Synapse integrates testing, medical history, patient explanation, instruction, and long-term progress management tools in one connected clinical system.
Paravellum and ConvergePartners Leadership
Paravellum was established on September 1, 2025, in Shibuya-ku, Tokyo, according to Paravellum’s corporate website. Haruki Sagara is the CEO of Paravellum. Sagara says, “Utilizing AI technology in practical work requires a technology base that properly handles data quality, structure, and information relationships.”
ConvergePartners was established on July 7, 2025, in Saitama City, Saitama, according to the ConvergePartners company page. Yuya Tosaka is the CEO. Tosaka says, “We use the clinical perspective of understanding patient conditions alongside progress and instruction details as the starting point for product development.”
Questions about Synapse Dental AI and Paravellum
What is the goal of the Synapse platform?
Also Read: UCB Expands CRM Capabilities With Veeva Vault
ConvergePartners aims to connect information and progress per patient in cross-disciplinary dental fields such as periodontal disease, oral hypofunction, implants, and sleep dentistry. The system acts as a single point of entry.
How does the new infrastructure support future AI development?
The data integration infrastructure supports future research. The system tracks specific measuring methods alongside historical test results to prepare structured clinical data for new AI models.
What services do Paravellum and ConvergePartners offer?
Paravellum handles AI and cloud system development. ConvergePartners develops DX products for dentistry, clinical consulting services, professional seminars, and specialized education for human resources.


